Anastasiya E. Kuchina

Anastasiya E. Kuchina

Auto-generated profile, based on publicly available information

Anastasiya E. Kuchina

Russian Medical Academy of Continuous Professional Education

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2023 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
ODOlga V. Dedikova
Olga V. Dedikova
IZIrina Zakharova
Irina Zakharova
AKAnastasiya E. Kuchina
Anastasiya E. Kuchina
IBIrina V. Berezhnaya
Irina V. Berezhnaya
NSNarine G. Sugian
Narine G. Sugian
Many studies have been devoted to human microbiome. It has been shown that the microbiome has a significant effect on almost all the vital functions of the host organism. The article addresses the role of various factors in newborns' intestinal microbiota formation. The main emphasis was on the delivery method since the intestinal microbiota of children born via vaginal delivery differs from those born by cesarean section. The microbiota of the mother's intestine and vagina greatly influences the formation of the intestinal microbiome. The delivery method affects not only the formation of the intestinal microbiota but also, indirectly, the development of the newborn's immune system. Changes in the intestinal microbiota associated with surgical delivery probably affect the formation of a newborn infant's immune system. Lack of colonization by the mother's flora during delivery may contribute to a greater risk of infectious and non-communicable diseases. Correcting the microbiota of children born by cesarean section using probiotics (mono- or multistrain probiotics) is essential. When prescribing a probiotic, it is important to choose a well-studied strain shown to be safe, with a positive experience in newborns, and approved for use in children from birth.

8 June 2024 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
SKStanislav I. Koshechkin
Stanislav I. Koshechkin
VOVera Odintsova
Vera Odintsova
AKAlexander V. Karasev
Alexander V. Karasev
IZIrina Zakharova
Irina Zakharova
IBIrina V. Berezhnaya
Irina V. Berezhnaya
МВМахаева Анастасия Владимировна
Махаева Анастасия Владимировна
Current omics methods, which are essential for scientific research, are overviewed. These methods enable studies of the mechanisms of clinical manifestations by analyzing the relationship between the microbiota characteristics and clinical parameters. To represent the complex interactions between the microbiome and host metabolism, metagenomics and metabolomics techniques that contribute to the search for new therapeutic approaches are most relevant. Based on the metagenomic data, the associated taxa are searched, and the metabolic profile indicates the result of the activity of the microbial community. The characteristics of technologies for studying metagenomes using the amplicon sequencing method are considered, and the depth of identification of microorganisms, the level of sequencing errors and the preference in terms of cost are evaluated. Studying the evolution of pathogens and metabolic processes, expressed genes, and determinants of antibiotic resistance contributes to the development of rational strategies for disease therapy and control of the spread of infectious diseases. In recent years, the number of scientific projects in the field of microbiota research has been steadily increasing, which necessitates the need to raise physicians' awareness of modern methods and research approaches in order to apply relevant data in practical work.

25 February 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
IZIrina Zakharova
Irina Zakharova
AКA. E. Кuchina
A. E. Кuchina
Scientific discoveries of recent years demonstrate a crucial role of the human microbiome in human health. The establishment of a healthy, functional gut microbiota of the newborn requires physiological conditions, one of which is breastfeeding. The role of breast milk as a “direct supplier” of live microbes for the establishment of the newborn gut microbiota became known only at the beginning of the new millennium, previously it was believed that the breast milk was sterile. Today, the breast milk microbiota can be defined as multi-species assemblage, in which microbes interact with each, representing a complex organized ecosystem, among which the genera Streptococcus and Staphylococcus are dominant. Lactobacillus, Pseudomonas, Bifidobacterium, Corynebacterium, Enterococcus, Acinetobacter, Rothia, Cutibacterium, Veillonella and Bacteroides are also often referred to the common bacterial genera. The article presents two theories of the origin of bacteria in the breast milk (endogenous and exogenous bacterial translocation pathways) and explains why both of them are true. The role of bacteria in the breast milk of healthy women, in the global sense, is viewed in the context of the establishment of the infant gut microbiota. The article lists the main producers of antibacterial peptides (bacteriocins) in the breast milk and considers the effective immunological protection using the example of the population of bifidobacteria and bacteroids prevailing in the breastfed infant gut. However, the breast milk microbiota is also important for women’s health. We tried to explain why infectious lactational mastitis is now considered to be the result of dysbiosis in the mammary ecosystem, which leads to the development of an inflammatory process, and why Streptococcus thermophilus (TCI633) shows promise in the fight against human ageing.

26 February 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ОDО. V. Dedikova
О. V. Dedikova
IZIrina Zakharova
Irina Zakharova
AKA. E. Kuchina
A. E. Kuchina
IBI. V. Berezhnaya
I. V. Berezhnaya
NSN. G. Sugian
N. G. Sugian
MAM. D. Ardatskaya
M. D. Ardatskaya
Introduction. Studying the gut microbiota of C-section newborns and its correction is a topical problem at present.Aim. To study the process of gut microbiota formation in healthy C-section infants, and the option for its correction using a Lactobacillus reuteri strain DSM 17938 probiotic.Materials and methods. A total of 80 healthy newborns were included in the study. Of these, 59 completed the study: the treatment group consisted of 36 elective caesarean (EC)-section infants and the control group was made up of 23 vaginally delivered infants. Newborns of the treatment study group were randomized into subgroups, one of which received the L. reuteri strain DSM 17938 (L subgroup) probiotic, and the second one did not receive it (0 subgroup). During the entire period of the study, infants were exclusively breastfed. The gut microbiota was analysed with the 16S rRNA sequencing method, and the metabolic activity of the gut microbiota was additionally assessed using gas-liquid chromatography.Results and discussion. The metagenomic analysis showed that the taxonomic richness and biological diversity of the gut microbiota in L subgroup infants increased in time interval 3, which indicated the active effect of the strain on the infant microbiota by Exposure Day 30. The gas-liquid chromatography analysis showed more pronounced changes in short-chain fatty acids in infants of the L subgroup: they were more similar to the findings in the control group (vaginal delivery). Also, bowel problems and allergies occurred less frequently in infants of this subgroup and they less frequently suffered from respiratory diseases during the year. The study showed the association between the mode of delivery and changes in anthropometric measurements.Conclusion. The use of L. reuteri strain DSM 17938 probiotic had a significant effect on the formation of the microbiota by the 30th day of age. A daily long-term addition of a L. reuteri strain DSM 17938 probiotic can prevent early microbiota dysbiosis and have a protective effect in later age period.

25 April 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AKA. E. Kuchina
A. E. Kuchina
IZIrina Zakharova
Irina Zakharova
The autonomous regulation of the composition of breast milk according to the baby’s needs is perhaps the most unique and mysterious mechanism. Under physiological conditions, the first drops of milk are rich in antioxidants that the newborn needs to combat oxygen deprivation. Milk to nourish boys is more nutritious and night milk is rich in melatonin, which can soothe and put the baby to sleep. Unfortunately, the conditions surrounding a pregnant woman and her newborn baby are not always natural. Many external factors are considered in the context of the risk of adverse effects on the health of the mother and the baby. This article discusses the most common factors that distort the microbiota of breast milk: obesity, delivery mode and antibiotic prophylaxis. Caesarean section, which significantly depletes the bacterial diversity of breast milk, is reported to be the most important factor. The associated disruption of microbial colonisation in infancy leads to a high risk of inflammatory bowel disease (including Crohn’s disease and ulcerative colitis), diabetes mellitus, rheumatoid arthritis and celiac disease in children. However, there is another opinion that attributes all the consequences of caesarean section to the necessary preoperative antibiotic prophylaxis in most countries. Maternal obesity also leads to low microbial diversity and impoverishment of breast milk with members of the Bifidobacterium genus, which in turn leads to reduced immunomodulatory potential of breast milk in these women. Often these three factors constitute a vicious circle of problems that interfere with the natural and proper process of forming a healthy microbiome in the newborn and require individualised and professional paediatric care.

12 July 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
ODO. V. Dedikova
O. V. Dedikova
AKA. E. Kuchina
A. E. Kuchina
IBI. V. Berezhnaya
I. V. Berezhnaya
IZIrina Zakharova
Irina Zakharova
The history of the use of fermented, easily digestible products in the treatment and for prolonging life began long before their basis was called probiotics. Recipes for fermenting milk from various animals, endowing it with healing properties, have a long history. The first descriptions of fermentation of milk for making sour milk drinks and cheese are documented in the sacred writings of Indians and date back to about 2000 B.C. The first attempts to explain the secrets of sour milk began only in the second half of the XIX century and are associated with the works of outstanding scientists of the time - Louis Pasteur, Henri Tissier, I.I. Mechnikov, Stamen Grigorov and others. Today, in the usual sense, probiotics are living microorganisms that benefit the host when administered in adequate quantities. It is quite obvious that belonging of a probiotic strain to different species and types of bacteria determines a different set of immunological and non-immunological effects, as well as a number of specific, unique qualities.Lactobacillus reuteriis one of the most well-studied species with respect to both efficacy and safety. The beneficial health effects ofL. reuteristrains (DSM 17938, ATCC PTA 6475, ATCC PTA 52899) have been confirmed in more than 200 clinical trials with the participation of about 18,000 people of all ages. The article most fully describes the effects ofL. reuteriDSM 17938, the use of which is not limited to the well-known means of prevention and treatment of infantile colic.